# Federal Register #2026-21360

DEA Registration Application for Scottsdale Research Institute to Manufacture Ibogaine for Research

**Buyer:** Drug Enforcement Administration
**Posted:** October 19, 2026
**Respond By:** December 18, 2026
**Identifier:** 2026-21360

The Department of Justice’s Drug Enforcement Administration is considering Scottsdale Research Institute’s application to manufacture ibogaine for research and clinical trials.
- **Notice type:** Regulatory registration notice, not a procurement solicitation or contract award.
- **Government agency:** U.S. Department of Justice (DOJ), Drug Enforcement Administration (DEA).
- **Applicant:** Scottsdale Research Institute seeks registration as a bulk manufacturer of ibogaine, a controlled substance.
- **Proposed activity:** Manufacture ibogaine for the institute’s internal research and to support clinical trials; no other activity involving ibogaine is authorized under the proposed registration.
- **Procurement items and quantities:** No products or services are being purchased, and no quantities or part numbers are specified.
- **Eligible parties:** Registered bulk manufacturers and applicants may submit comments or objections, or request a hearing.

### Description

Scottsdale Research Institute applied to be registered as a bulk manufacturer of ibogaine, a basic class of controlled substance. The company plans to manufacture the substance for internal research purposes and to support clinical trials; no other activity for this drug code is authorized under the registration. Eligible registered bulk manufacturers and applicants may submit comments or objections, or request a hearing, by December 18, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/10/19/2026-21360/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute)